NR

NEWPARK RESOURCES TO ATTEND THE 14TH ANNUAL CRAIG-HALLUM ALPHA SELECT CONFERENCE

Retrieved on: 
木曜日, 11月 9, 2023

THE WOODLANDS, Texas, Nov. 9, 2023 /PRNewswire/ -- Newpark Resources, Inc. (NYSE: NR) ("Newpark" or the "Company") today announced that members of senior management will attend the 14th Annual Craig-Hallum Alpha Select Conference at the Sheraton Times Square Hotel in New York City on Thursday, November 16, 2023.

Key Points: 
  • THE WOODLANDS, Texas, Nov. 9, 2023 /PRNewswire/ -- Newpark Resources, Inc. (NYSE: NR) ("Newpark" or the "Company") today announced that members of senior management will attend the 14th Annual Craig-Hallum Alpha Select Conference at the Sheraton Times Square Hotel in New York City on Thursday, November 16, 2023.
  • In conjunction with the event, Newpark executives will be available to participate in one-on-one meetings with investors registered to attend the conference.
  • For more information, please contact your Craig-Hallum representative.

ChromaDex Corporation Reports Third Quarter 2023 Financial Results

Retrieved on: 
水曜日, 11月 8, 2023

ChromaDex Corp. (NASDAQ: CDXC) today announced financial results for the third quarter of 2023.

Key Points: 
  • ChromaDex Corp. (NASDAQ: CDXC) today announced financial results for the third quarter of 2023.
  • Strong gross margin of 61.4%, an increase of 160 basis points, compared to 59.8% from the prior year quarter.
  • Adjusted EBITDA, a non-GAAP measure, was a positive $0.5 million, a $1.7 million improvement from the prior year quarter.
  • In October 2023, Zesty Paws, a prominent name in pet supplements, partnered with ChromaDex to launch a Healthy Aging NAD+ Precursor supplement for pets, featuring Niagen®.

ChromaDex Debuts Clinical Strength Tru Niagen® Pro 1,000mg Featuring Niagen® (Patented Nicotinamide Riboside), One of the Most Efficient Nicotinamide Adenine Dinucleotide (NAD+) Boosters Available, to Consumers Nationwide

Retrieved on: 
水曜日, 11月 1, 2023

ChromaDex Corp. (NASDAQ:CDXC), a global authority on Nicotinamide Adenine Dinucleotide (NAD+) research and healthy aging, launches its clinical strength Tru Niagen® Pro 1,000mg , featuring 1,000mg of Niagen® (patented Nicotinamide Riboside or NR), one of the most efficient and superior quality NAD+ precursors on the market, to consumers nationwide.

Key Points: 
  • ChromaDex Corp. (NASDAQ:CDXC), a global authority on Nicotinamide Adenine Dinucleotide (NAD+) research and healthy aging, launches its clinical strength Tru Niagen® Pro 1,000mg , featuring 1,000mg of Niagen® (patented Nicotinamide Riboside or NR), one of the most efficient and superior quality NAD+ precursors on the market, to consumers nationwide.
  • With 1,000mg of Niagen used in over 50% of published clinical studies, this serving is redefining research for NAD+ related health outcomes.
  • “As a pioneer of NAD+ research, our team works with esteemed investigators across the globe to uncover the full potential of NAD+.
  • Tru Niagen Pro 1,000mg was unveiled to a select group of Key Opinion Leaders (KOLs), physicians, influencers and celebrities at the Tru Niagen Wellness Retreat in Malibu last week.

Drilling Continues at JR Zone While Ground Geophysics Commences on A1B

Retrieved on: 
火曜日, 10月 24, 2023

Mobilization has commenced for a 3D ground resistivity survey to obtain a signature over the JR Zone and to develop targets for drilling in 2024 over the A1B conductor, ~3km south of the JR Zone, and the newly defined southeastern 1.3km extension to the conductive corridor.

Key Points: 
  • Mobilization has commenced for a 3D ground resistivity survey to obtain a signature over the JR Zone and to develop targets for drilling in 2024 over the A1B conductor, ~3km south of the JR Zone, and the newly defined southeastern 1.3km extension to the conductive corridor.
  • "Drilling continues at the JR Zone filling in up and down dip on section lines where the mineralization remains open.
  • A second drill is also continuing to focus on exploration drilling to the south of the JR Zone along the A1B conductor where encouraging signs for potential proximal mineralization are being encountered.
  • We are excited that the ground 3D resistivity survey is about to commence to provide a signature over the JR Zone and to help define targets for the aggressive drilling programs coming in 2024 that will allow us to home in on the next mineralized zone along the newly extended A1 and A1B conductive corridor.

ALZINC and NEXUS LIFE SCIENCES LAB INC. Unveil the Norige Youth Initiative, a Game-Changer in the Realm of Anti-Aging Technology

Retrieved on: 
月曜日, 10月 23, 2023

ALZINC and NEXUS LIFE SCIENCES LAB INC. have introduced the Norige Youth Initiative, a pioneering global consortium that seeks to revolutionize anti-aging technology with the potential to extend the human lifespan and transform the societal and economic approach to aging and wellness.

Key Points: 
  • The Norige Youth Initiative is set to revolutionize our understanding of aging and promises to be a game-changer in the realm of anti-aging technology.
  • ALZINC and NEXUS LIFE SCIENCES LAB INC.
  • Unveil the Norige Youth Initiative, a Game-Changer in the Realm of Anti-Aging Technology
    To view an enhanced version of this graphic, please visit:
    This initiative represents a paradigm shift in the field of anti-aging research.
  • In unveiling the Norige Youth Initiative, ALZINC and NEXUS LIFE SCIENCES LAB INC. have embarked on a transformative journey in anti-aging technology.

Brixton Metals Yields up to 33% Copper and 39 g/t Gold from 2023 Surface Sampling Results at the East Target and South Target, Thorn Project

Retrieved on: 
火曜日, 10月 24, 2023

Brixton has 14 recognized copper-gold-silver targets at the wholly owned Thorn Project, located in Northwestern British Columbia, Canada.

Key Points: 
  • Brixton has 14 recognized copper-gold-silver targets at the wholly owned Thorn Project, located in Northwestern British Columbia, Canada.
  • Surface geochemical sampling was conducted across multiple target zones including the Metla, Plum, Trapper, North, East, West and South Targets as well as additional regional target areas across the project.
  • While the majority of 2023 surface sample assay results are yet to be received, highlights from recent assay results are reported herein for the South, East, Metla, Plum, and Trapper Targets.
  • Highlights from the 2023 sampling program at South Target are listed in Table 1 and illustrated in Figure 2.

T-Mobile’s Ultra Capacity 5G Covers 300 Million People Months Ahead of Schedule

Retrieved on: 
火曜日, 10月 24, 2023

T-Mobile (NASDAQ: TMUS) today announced it has expanded its Ultra Capacity 5G network to cover 300 million people – reaching the goal months ahead of schedule!

Key Points: 
  • T-Mobile (NASDAQ: TMUS) today announced it has expanded its Ultra Capacity 5G network to cover 300 million people – reaching the goal months ahead of schedule!
  • View the full release here: https://www.businesswire.com/news/home/20231024150793/en/
    T-Mobile’s Ultra Capacity 5G Covers 300 Million People Months Ahead of Schedule (Graphic: Business Wire)
    “We have been leaders in the 5G era from the start, deploying the largest, fastest, most awarded and most advanced 5G network in the country faster than anyone else,” said Ulf Ewaldsson, President of Technology at T-Mobile.
  • In fact, T-Mobile’s Ultra Capacity 5G covers more square miles than the mid-band 5G networks of the other guys combined!
  • No other provider has even stated plans to achieve the level of 5G capacity and reach that T-Mobile is delivering today.

Solgar® Cellular Nutrition Emerges to Take Longevity Cell Deep

Retrieved on: 
火曜日, 10月 24, 2023

HOBOKEN, N.J., Oct. 24, 2023 /PRNewswire/ -- Solgar®, a Nestlé Health Science brand and a leader in scientifically-backed vitamin and nutritional supplements for more than 70 years, today unveiled its Solgar® Cellular Nutrition line of dietary supplements developed to help fight cellular decline and promote cell health. Solgar Cellular Nutrition's products – Energy, Strength & Renewal, and Protect – target cellular decline through clinically studied ingredients, including Nicotinamide Riboside (NR), Urolithin A (UA) as well as Glycine & N-Acetyl Cysteine (GlyNAC). These products are available online through Solgar Cellular Nutrition at www.solgar.com/cellular-nutrition.  

Key Points: 
  • These products are available online through Solgar Cellular Nutrition at www.solgar.com/cellular-nutrition .
  • "These scientific advances along with new cellular nutrition research led us to develop our new line of Solgar Cellular Nutrition products.
  • These products – Energy, Strength & Renewal, and Protect – feature nutrients that work with the body's natural processes deep inside cells to help fight sources of cellular decline and promote overall cell health.
  • To learn more about Solgar Cellular Nutrition and purchase its cellular health products, please visit www.solgar.com/cellular-nutrition .

Lendbuzz Completes $235 Million Asset-Backed Securitization

Retrieved on: 
水曜日, 10月 18, 2023

J.P. Morgan acted as lead bookrunner and structuring agent, with Goldman Sachs and RBC as joint bookrunners.

Key Points: 
  • J.P. Morgan acted as lead bookrunner and structuring agent, with Goldman Sachs and RBC as joint bookrunners.
  • said George Sclavos, Chief Financial Officer at Lendbuzz.
  • This transaction, Lendbuzz’s third securitization of 2023 and fifth since launching the program, is its largest transaction in program history and continues a period of record-breaking success for the company.
  • This securitization also included over 20 distinct investors, expanding Lendbuzz’s program with 8 first-time investors.

NEWPARK RESOURCES ANNOUNCES THIRD QUARTER 2023 RESULTS CONFERENCE CALL AND WEBCAST DATE

Retrieved on: 
水曜日, 10月 18, 2023

THE WOODLANDS, Texas, Oct. 18, 2023 /PRNewswire/ -- Newpark Resources, Inc. (NYSE: NR) ("Newpark" or the "Company") today announced that it will issue third quarter 2023 results after the U.S. markets close on Tuesday, October 31, 2023.

Key Points: 
  • THE WOODLANDS, Texas, Oct. 18, 2023 /PRNewswire/ -- Newpark Resources, Inc. (NYSE: NR) ("Newpark" or the "Company") today announced that it will issue third quarter 2023 results after the U.S. markets close on Tuesday, October 31, 2023.
  • A conference call will be held the following day on Wednesday, November 1, 2023 at 9:30 a.m.
  • ET to review the Company's financial results and conduct a question-and-answer session.
  • A webcast of the conference call and accompanying presentation materials will be available in the Investor Relations section of the Company's website at https://investor.newpark.com/ .